DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Multidrug Efflux Pumps and the Two-Faced Janus of Substrates and Inhibitors

Abstract

Antibiotics are miracle drugs that can cure infectious bacterial diseases. However, their utility is challenged by antibiotic resistant bacteria emerging in clinics and straining the modern medicine and our ways of life. Certain bacteria such as Gram-negative (Gram(- )) and Mycobacteriales species are intrinsically resistant to most clinical antibiotics and can further gain multidrug resistance through mutations and plasmid acquisition. These species stand out by the presence of an additional external lipidic membranes (the outer membrane, OM) that are composed of unique glycolipids. Although formidable, the OM is a passive permeability barrier that can reduce penetration of antibiotics but cannot affect intracellular steady-state concentrations of drugs. The two-membrane envelopes are further reinforced by active efflux transporters that expel antibiotics from cells against their concentration gradients. The major mechanism of antibiotic resistance in Gram(-) pathogens is the active efflux of drugs, which acts synergistically with the low permeability barrier of the OM and other mutational and plasmid-borne mechanisms of antibiotic resistance.

Authors:
ORCiD logo [1]; ORCiD logo [2]; ORCiD logo [3]; ORCiD logo [1]
  1. Univ. of Oklahoma, Norman, OK (United States)
  2. St. Louis Univ., MI (United States)
  3. Oak Ridge National Lab. (ORNL), Oak Ridge, TN (United States)
Publication Date:
Research Org.:
Oak Ridge National Lab. (ORNL), Oak Ridge, TN (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1772625
Grant/Contract Number:  
AC05-00OR22725
Resource Type:
Accepted Manuscript
Journal Name:
Accounts of Chemical Research
Additional Journal Information:
Journal Volume: 54; Journal Issue: 4; Journal ID: ISSN 0001-4842
Publisher:
American Chemical Society
Country of Publication:
United States
Language:
English
Subject:
37 INORGANIC, ORGANIC, PHYSICAL, AND ANALYTICAL CHEMISTRY; Inhibitors; Antibiotic resistance; Antimicrobial agents; Bacteria; Membranes

Citation Formats

Zgurskaya, Helen I., Walker, John K., Parks, Jerry M., and Rybenkov, Valentin V. Multidrug Efflux Pumps and the Two-Faced Janus of Substrates and Inhibitors. United States: N. p., 2021. Web. doi:10.1021/acs.accounts.0c00843.
Zgurskaya, Helen I., Walker, John K., Parks, Jerry M., & Rybenkov, Valentin V. Multidrug Efflux Pumps and the Two-Faced Janus of Substrates and Inhibitors. United States. https://doi.org/10.1021/acs.accounts.0c00843
Zgurskaya, Helen I., Walker, John K., Parks, Jerry M., and Rybenkov, Valentin V. Thu . "Multidrug Efflux Pumps and the Two-Faced Janus of Substrates and Inhibitors". United States. https://doi.org/10.1021/acs.accounts.0c00843. https://www.osti.gov/servlets/purl/1772625.
@article{osti_1772625,
title = {Multidrug Efflux Pumps and the Two-Faced Janus of Substrates and Inhibitors},
author = {Zgurskaya, Helen I. and Walker, John K. and Parks, Jerry M. and Rybenkov, Valentin V.},
abstractNote = {Antibiotics are miracle drugs that can cure infectious bacterial diseases. However, their utility is challenged by antibiotic resistant bacteria emerging in clinics and straining the modern medicine and our ways of life. Certain bacteria such as Gram-negative (Gram(- )) and Mycobacteriales species are intrinsically resistant to most clinical antibiotics and can further gain multidrug resistance through mutations and plasmid acquisition. These species stand out by the presence of an additional external lipidic membranes (the outer membrane, OM) that are composed of unique glycolipids. Although formidable, the OM is a passive permeability barrier that can reduce penetration of antibiotics but cannot affect intracellular steady-state concentrations of drugs. The two-membrane envelopes are further reinforced by active efflux transporters that expel antibiotics from cells against their concentration gradients. The major mechanism of antibiotic resistance in Gram(-) pathogens is the active efflux of drugs, which acts synergistically with the low permeability barrier of the OM and other mutational and plasmid-borne mechanisms of antibiotic resistance.},
doi = {10.1021/acs.accounts.0c00843},
journal = {Accounts of Chemical Research},
number = 4,
volume = 54,
place = {United States},
year = {Thu Feb 04 00:00:00 EST 2021},
month = {Thu Feb 04 00:00:00 EST 2021}
}

Works referenced in this record:

Practical applications and feasibility of efflux pump inhibitors in the clinic—A vision for applied use
journal, March 2006


Metal-induced conformational changes in ZneB suggest an active role of membrane fusion proteins in efflux resistance systems
journal, June 2010

  • De Angelis, F.; Lee, J. K.; O'Connell, J. D.
  • Proceedings of the National Academy of Sciences, Vol. 107, Issue 24
  • DOI: 10.1073/pnas.1003908107

Bifurcation kinetics of drug uptake by Gram-negative bacteria
journal, September 2017


Breaking the permeability barrier of Escherichia coli by controlled hyperporination of the outer membrane.
journal, October 2016

  • Krishnamoorthy, Ganesh; Wolloscheck, David; Weeks, Jon W.
  • Antimicrobial Agents and Chemotherapy
  • DOI: 10.1128/AAC.01882-16

Discovery of multidrug efflux pump inhibitors with a novel chemical scaffold
journal, June 2020

  • Green, Adam T.; Moniruzzaman, Mohammad; Cooper, Connor J.
  • Biochimica et Biophysica Acta (BBA) - General Subjects, Vol. 1864, Issue 6
  • DOI: 10.1016/j.bbagen.2020.129546

Multidrug efflux pumps in Gram-negative bacteria and their role in antibiotic resistance
journal, October 2014

  • Blair, Jessica MA; Richmond, Grace E.; Piddock, Laura JV
  • Future Microbiology, Vol. 9, Issue 10
  • DOI: 10.2217/fmb.14.66

On the role of TolC in multidrug efflux: the function and assembly of AcrAB-TolC tolerate significant depletion of intracellular TolC protein: Role of TolC in multidrug efflux
journal, January 2013

  • Krishnamoorthy, Ganesh; Tikhonova, Elena B.; Dhamdhere, Girija
  • Molecular Microbiology, Vol. 87, Issue 5
  • DOI: 10.1111/mmi.12143

Kinetic control of TolC recruitment by multidrug efflux complexes
journal, September 2009

  • Tikhonova, E. B.; Dastidar, V.; Rybenkov, V. V.
  • Proceedings of the National Academy of Sciences, Vol. 106, Issue 38
  • DOI: 10.1073/pnas.0906601106

Porins and small-molecule translocation across the outer membrane of Gram-negative bacteria
journal, December 2019

  • Vergalli, Julia; Bodrenko, Igor V.; Masi, Muriel
  • Nature Reviews Microbiology, Vol. 18, Issue 3
  • DOI: 10.1038/s41579-019-0294-2

Transporters Involved in the Biogenesis and Functionalization of the Mycobacterial Cell Envelope
journal, November 2020


Structure–Function Profile of MmpL3, the Essential Mycolic Acid Transporter from Mycobacterium tuberculosis
journal, September 2016


AcrB: a mean, keen, drug efflux machine
journal, September 2019

  • Kobylka, Jessica; Kuth, Miriam S.; Müller, Reinke T.
  • Annals of the New York Academy of Sciences, Vol. 1459, Issue 1
  • DOI: 10.1111/nyas.14239

Molecular basis for inhibition of AcrB multidrug efflux pump by novel and powerful pyranopyridine derivatives
journal, March 2016

  • Sjuts, Hanno; Vargiu, Attilio V.; Kwasny, Steven M.
  • Proceedings of the National Academy of Sciences, Vol. 113, Issue 13
  • DOI: 10.1073/pnas.1602472113

Structure of the Ligand-blocked Periplasmic Entrance of the Bacterial Multidrug Efflux Protein TolC
journal, September 2004

  • Higgins, Matthew K.; Eswaran, Jeyanthy; Edwards, Patricia
  • Journal of Molecular Biology, Vol. 342, Issue 3
  • DOI: 10.1016/j.jmb.2004.07.088

Aminoacyl β-naphthylamides as substrates and modulators of AcrB multidrug efflux pump
journal, January 2016

  • Kinana, Alfred D.; Vargiu, Attilio V.; May, Thithiwat
  • Proceedings of the National Academy of Sciences, Vol. 113, Issue 5
  • DOI: 10.1073/pnas.1525143113

Kinetic Control of Quorum Sensing in Pseudomonas aeruginosa by Multidrug Efflux Pumps
journal, November 2017

  • Wolloscheck, David; Krishnamoorthy, Ganesh; Nguyen, Jennifer
  • ACS Infectious Diseases, Vol. 4, Issue 2
  • DOI: 10.1021/acsinfecdis.7b00160

Identification and Characterization of Inhibitors of Multidrug Resistance Efflux Pumps in Pseudomonas aeruginosa: Novel Agents for Combination Therapy
journal, January 2001


The C-Terminal Domain of AcrA Is Essential for the Assembly and Function of the Multidrug Efflux Pump AcrAB-TolC
journal, May 2009

  • Ge, Qiang; Yamada, Yoichi; Zgurskaya, Helen
  • Journal of Bacteriology, Vol. 191, Issue 13
  • DOI: 10.1128/JB.00204-09

Molecular Properties That Define the Activities of Antibiotics in Escherichia coli and Pseudomonas aeruginosa
journal, May 2018

  • Cooper, Sarah J.; Krishnamoorthy, Ganesh; Wolloscheck, David
  • ACS Infectious Diseases, Vol. 4, Issue 8
  • DOI: 10.1021/acsinfecdis.8b00036

Structural and Functional Diversity of Resistance–Nodulation–Cell Division Transporters
journal, November 2020


Inactivation of AdeABC and AdeIJK efflux pumps elicits specific nonoverlapping transcriptional and phenotypic responses in Acinetobacter baumannii
journal, September 2020

  • Leus, Inga V.; Adamiak, Justyna; Trinh, Anhthu N.
  • Molecular Microbiology, Vol. 114, Issue 6
  • DOI: 10.1111/mmi.14594

Coupling of remote alternating-access transport mechanisms for protons and substrates in the multidrug efflux pump AcrB
journal, September 2014


The challenge of converting Gram-positive-only compounds into broad-spectrum antibiotics: Challenges in developing broad-spectrum antibiotics
journal, February 2018

  • Richter, Michelle F.; Hergenrother, Paul J.
  • Annals of the New York Academy of Sciences, Vol. 1435, Issue 1
  • DOI: 10.1111/nyas.13598

Reconstitution of the Escherichia coli macrolide transporter: the periplasmic membrane fusion protein MacA stimulates the ATPase activity of MacB
journal, February 2007


An allosteric transport mechanism for the AcrAB-TolC multidrug efflux pump
journal, March 2017


Structural Asymmetry of AcrB Trimer Suggests a Peristaltic Pump Mechanism
journal, September 2006


In situ structure and assembly of the multidrug efflux pump AcrAB-TolC
journal, June 2019


Drug Permeation against Efflux by Two Transporters
journal, February 2020


Crystal Structures of Membrane Transporter MmpL3, an Anti-TB Drug Target
journal, January 2019


A “Drug Sweeping” State of the TriABC Triclosan Efflux Pump from Pseudomonas aeruginosa
journal, March 2021


Conformational Dynamics of AcrA Govern Multidrug Efflux Pump Assembly
journal, September 2019


Bypassing the periplasm: Reconstitution of the AcrAB multidrug efflux pump of Escherichia coli
journal, June 1999

  • Zgurskaya, H. I.; Nikaido, H.
  • Proceedings of the National Academy of Sciences, Vol. 96, Issue 13
  • DOI: 10.1073/pnas.96.13.7190

Efflux Pumps of Burkholderia thailandensis Control the Permeability Barrier of the Outer Membrane
journal, August 2019

  • Krishnamoorthy, Ganesh; Weeks, Jon W.; Zhang, Zhen
  • Antimicrobial Agents and Chemotherapy, Vol. 63, Issue 10
  • DOI: 10.1128/AAC.00956-19

Sequential Mechanism of Assembly of Multidrug Efflux Pump AcrAB-TolC
journal, April 2011


Identification of Binding Sites for Efflux Pump Inhibitors of the AcrAB-TolC Component AcrA
journal, February 2019

  • Darzynkiewicz, Zbigniew M.; Green, Adam T.; Abdali, Narges
  • Biophysical Journal, Vol. 116, Issue 4
  • DOI: 10.1016/j.bpj.2019.01.010

Constant pH Molecular Dynamics Reveals How Proton Release Drives the Conformational Transition of a Transmembrane Efflux Pump
journal, November 2017

  • Yue, Zhi; Chen, Wei; Zgurskaya, Helen I.
  • Journal of Chemical Theory and Computation, Vol. 13, Issue 12
  • DOI: 10.1021/acs.jctc.7b00874

Permeability barriers of Gram‐negative pathogens
journal, June 2019

  • Zgurskaya, Helen I.; Rybenkov, Valentin V.
  • Annals of the New York Academy of Sciences, Vol. 1459, Issue 1
  • DOI: 10.1111/nyas.14134

AcrA, AcrB, and TolC of Escherichia coli Form a Stable Intermembrane Multidrug Efflux Complex
journal, July 2004

  • Tikhonova, Elena B.; Zgurskaya, Helen I.
  • Journal of Biological Chemistry, Vol. 279, Issue 31
  • DOI: 10.1074/jbc.M402230200

Trans-envelope multidrug efflux pumps of Gram-negative bacteria and their synergism with the outer membrane barrier
journal, September 2018

  • Zgurskaya, Helen I.; Rybenkov, Valentin V.; Krishnamoorthy, Ganesh
  • Research in Microbiology, Vol. 169, Issue 7-8
  • DOI: 10.1016/j.resmic.2018.02.002

New Multidrug Efflux Inhibitors for Gram-Negative Bacteria
journal, July 2020

  • Marshall, Robert L.; Lloyd, Georgina S.; Lawler, Amelia J.
  • mBio, Vol. 11, Issue 4
  • DOI: 10.1128/mBio.01340-20

Direct Inhibition of MmpL3 by Novel Antitubercular Compounds
journal, March 2019


Immunization with outer membrane proteins (OprF and OprI) and flagellin B protects mice from pulmonary infection with mucoid and nonmucoid Pseudomonas aeruginosa
journal, June 2018

  • Hassan, Ramadan; El-Naggar, Wael; Abd El-Aziz, Abeer M.
  • Journal of Microbiology, Immunology and Infection, Vol. 51, Issue 3
  • DOI: 10.1016/j.jmii.2016.08.014

Structural basis for the inhibition of bacterial multidrug exporters
journal, June 2013

  • Nakashima, Ryosuke; Sakurai, Keisuke; Yamasaki, Seiji
  • Nature, Vol. 500, Issue 7460, p. 102-106
  • DOI: 10.1038/nature12300

Reviving Antibiotics: Efflux Pump Inhibitors That Interact with AcrA, a Membrane Fusion Protein of the AcrAB-TolC Multidrug Efflux Pump
journal, November 2016


The MmpL3 interactome reveals a complex crosstalk between cell envelope biosynthesis and cell elongation and division in mycobacteria
journal, July 2019


Predictive Rules of Efflux Inhibition and Avoidance in Pseudomonas aeruginosa
journal, January 2021

  • Mehla, Jitender; Malloci, Giuliano; Mansbach, Rachael
  • mBio, Vol. 12, Issue 1
  • DOI: 10.1128/mBio.02785-20